Matched ChIP-Validated Antibodies and Primer Sets from Chromatrap
Chromatrap announces that its high quality ChIP-validated antibodies can now be supplied with optimized matching primer sets
Chromatrap announces that its high quality ChIP-validated antibodies can now be supplied with optimized matching primer sets
Win a $500/£360/450€ Amazon voucher when you nominate and review your favorite life sciences products of 2015
Cobra and the CPI collaborate to develop an industrial manufacturing platform for adeno-associated virus production
Irvine Scientific announce the launch of BalanCDR CHO Feed 4
Learn how the Institute’s Department of Mechanical Engineering use JPK’s NanoTracker 2
Study suggests our organs may have their own sexual identity
Results from Genentech, Karolinska Institutet, National Jewish Health, and MD Anderson Cancer Center Highlight ICELL8™ Single-Cell System Performance
Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine
Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions
Alliance Combines the Power of Precise Single-Cell Isolation with Next Generation Sequencing
Sir Ranulph Fiennes attends launch event at the Source BioScience facility in Rochdale
SelectScience® spoke to a scientist and entrepreneur who believes the secret to love lies in our genes
Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific
Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection